Title: David Loeches Blas - Innovator in Pharmaceutical Technology
Introduction: David Loeches Blas is an inventor based in Barcelona, Spain. He is associated with Laboratorios Liconsa, S.A., where he contributes to the field of pharmaceutical technology. Although he currently holds no granted patents, his work is focused on developing innovative solutions for medical applications.
Latest Patent Applications: David Loeches Blas has submitted a patent application for an "Oral Pharmaceutical Tablet for Controlled Release of Mesalazine and Process for Obtaining It." This invention provides an oral pharmaceutical tablet designed for the controlled release of mesalazine or a pharmaceutically acceptable salt thereof as the active ingredient. The tablet features a core and a gastro-resistant outer coating, with the core comprising mesalazine and a hydrophilic matrix made from a mixture of hydroxypropylmethyl cellulose (HPMC) of varying viscosities. The gastro-resistant outer coating includes a pH-dependent release polymer along with pharmaceutically acceptable excipients. This invention aims to treat ulcerative colitis effectively.
Conclusion: David Loeches Blas is making strides in the pharmaceutical industry with his innovative approaches to drug delivery systems. His work has the potential to significantly impact the treatment of ulcerative colitis and improve patient outcomes.